Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement
Francesco Pollari(Paracelsus Medizinische Privatuniversität), Steffen Pfeiffer(Schön Klinik Vogtareuth), Jurij Matija Kališnik(Nuremberg Hospital), Christian Langhammer(Nuremberg Hospital), Claudius Söhn(Nuremberg Hospital), Theodor Fischlein(Nuremberg Hospital), Michela Cuomo(Nuremberg Hospital), Ferdinand Vogt(Paracelsus Medizinische Privatuniversität), Johannes Schwab(MRC Laboratory of Molecular Biology), Thomas Bertsch(Nuremberg Hospital), Wolfgang Hitzl(Paracelsus Medical University)
Cited by 56
Related Papers
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
|European Heart Journal|2017|334
Gender differences in the manifestation of tako-tsubo cardiomyopathy
|International Journal of Cardiology|2011|188
Complications in the clinical course of tako-tsubo cardiomyopathy
|International Journal of Cardiology|2014|174
Prognostic Implication of Right Ventricular Involvement in Peripartum Cardiomyopathy: A Cardiovascular Magnetic Resonance Study
|ESC Heart Failure|2015|97
Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis
|Journal of Thoracic and Cardiovascular Surgery|2020|89